Work

P2‐045: the Model‐ad Consortium Preclinical Testing Pipeline: Pharmacokinetics and Pharmacodynamics of Prophylactic Treatment With Levetiracetam in the 5xfad Mouse Model of Alzheimer's Disease

Year: 2018

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2018.06.729

Authors: Stacey J. Sukoff Rizzo, Sara K. Quinney, Kristen D. Onos, Kelly J. Keezer, David R. Jones, Andrea R. Masters, Ingrid F. Metzger, Jill A. Meyer, Jonathan Peters, Scott C. Persohn, Brian P. McCarthy, Amanda A. Riley, Michael Sasner, Gareth R. Howell, Harriett Williams, Adrian L. Oblak, Bruce T. Lamb, Paul Territo

Institutions: Jackson Laboratory, Indiana University School of Medicine, Indiana University Indianapolis, Indiana University

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2897244738

FWCI:

Cites:

Cited by:

Related to: 10